Shares rose after the Danish pharmaceutical group launched its anti-obesity drug Wegovy in the UK
Novo Nordisk Europe’s most valuable company based on closing price
Recent Posts
- Richard Caring sells majority stake in Ivy hospitality empire to Sheikh Tahnoon’s IHC
- How Iran turned to memes to take on Trump
- US and Iran begin highest-level talks in five decades
- Mortgage borrowers seek shorter-term deals as market volatility saps confidence
- Anthropic closes in on OpenAI as US business use surges
